2024 Chronic Pain Epilepsy 
Americans for Safe Access
AUGUST 12, 2025
January 2024: HHS Report to DEA on Scheduling Recommendation is Released May 2024 : DOJ/DEA publishes a Notice of Proposed Rulemaking (NPRM) to move marijuana from Schedule I to Schedule III, opening public comment (89 Fed. 70148 October 2024: Administrative Law Judge John J. . § 321(ff)(3)).
LifeCannMD
JUNE 23, 2025
Recent research continues to support cannabis as a legitimate medical treatment: Chronic Pain Management/Pain Relief That Actually Works: Here’s what the research shows – and what I see in my practice every day. But here’s the thing: that doesn’t mean we’re stuck.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Miss Marijuana
JANUARY 31, 2025
A mind-blowing study from 2024 showed that more than 70% of patients using medical marijuana saw major improvements in managing chronic conditions. Whether it’s helping with tough neurological issues or easing constant pain, cannabis is proving to be a game-changer in treatment. Chronic pain doesn’t have to control your life.
PrestoDoctor
JUNE 2, 2020
Forecasts state that the medical marijuana market will be worth more than $8 billion by 2024, and the global medical cannabis market is predicted to reach a net worth of $73.6 Some common qualifying ailments are: Cancer Chronic pain Nausea Anorexia Seizures/epilepsy ADHD HIV/AIDS Arthritis Glaucoma PTSD Insomnia Migraines and headaches.
Cannabis Law Report
DECEMBER 14, 2019
billion by 2024. The UK medicinal cannabis market value is forecast to reach almost US$1.3 Prohibition Partners’ has also estimated that up to 1 per-cent of the UK population could qualify as medical cannabis patients by 2028. Prohibition Partners estimates that there are as many as 3.6 million active cannabis users in the UK.
Cannabis Law Report
NOVEMBER 18, 2021
The global COVID-19 vaccine market is expected to grow to US$25 billion by 2024, and Latin America represents a substantial part. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.
Canna Law Blog
MARCH 11, 2024
HB 1453 seeks to alleviate the unfair tax burden on medical cannabis patients and providers On March 6, 2024, the Washington Senate passed HB 1453 which will provide an exemption from the 37% excise tax for medical cannabis patients and designated providers. The bill now waits for signatures and executive action to become law.
Expert insights. Personalized for you.
Let's personalize your content